This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
18 Apr 2011

Nycomed Gets Distribution Rights to Product Portfolio in Turkey

Nycomed replaces the specialty pharmaceutical company Biomeks ?la? (Biomeks) as the marketing authorization holder and distributor for the majority of Biomeks' product portfolio in Turkey.

Privately owned global pharmaceutical company Nycomed has reached several agreements with various pharmaceutical companies, including Almirall S.A., Anika Therapeutics, Inc., Bionorica AG, CSL Behring and Helsinn Healthcare SA.

 

With this transaction, Nycomed replaces the specialty pharmaceutical company Biomeks ?la? (Biomeks) as the marketing authorization holder and distributor for the majority of Biomeks' product portfolio in Turkey. The portfolio includes over ten pharmaceutical products, which generated €10 million in net sales in 2010.

 

Turkey is the six-largest pharmaceutical market in Europe, but is relatively fragmented. According to IMS Health, Turkey is expected to see double-digit growth on average through 2013.

Related News